The complex mechanisms of tumorigenesis and the inherent limitations of conventional therapies have severely restricted the clinical efficacy of tumor treatment. Owing to their pivotal roles in macromolecular degradation, energy metabolism, autophagy, and signal transduction, lysosomes are increasingly recognized as important targets for precision oncology. In this review, we summarize advances made over the past five years in the development of lysosome-specific chemical platforms for tumor the